Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors

References

• Krishnamurthy VM, Kaufman GK, Urbach, AR, et al. Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein–ligand binding. Chem Rev 2008;108:946–1051
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 2011;3:1165–80
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases as drug targets: general presentation. In: Supuran CT, Winum JY, eds. Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Hoboken (NJ): Wiley; 2009:15–38
   Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discovery 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Winum JY, Rami M, Scozzafava A, et al. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445–63
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2008;23:146–89
   Web of Science ®Google Scholar
• Winum JY, Supuran CT. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2014;18:1–4
   Google Scholar
• Supuran CT, Casini A, Scozzafava A. Development of sulfonamide carbonic anhydrase inhibitors. In: Supuran CT, Scozzafava A, Conway J, eds. Carbonic anhydrase: its inhibitors and activators. Boca Raton (FL): CRC Press; 2004:67–147
   Google Scholar
• Chohan ZH, Scozzafava A, Supuran CT. Zinc complexes of benzothiazole-derived Schiff bases with antibacterial activity. J Enzyme Inhib Med Chem 2003;18:259–63
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-bases drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23:693–704
   PubMed Web of Science ®Google Scholar
• Swenson ER. Safety of carbonic anhydrase inhibitors. Expert Opin Drug Saf 2014;13:459–72
   PubMed Web of Science ®Google Scholar
• Supuran CT, Mincione F, Scozzafava A, et al. Metal complexes of heterocyclic sulfonamides: a new class of strong topical intraocular pressure-lowering agents with potential use as antiglaucoma drugs. Eur J Med Chem 1998;33:247–54
   Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, Supuran CT. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68
   PubMed Web of Science ®Google Scholar
• Wilkinson BL, Bornaghi LF, Houston TA, et al. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IX with triazole-linked O-glycosides of benzene sulfonamides. J Med Chem 2007;50:1651–7
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Scozzafava A, Supuran CT. Unsymmetrical 1,1′-disubstituted ferrocenes: synthesis of Co(ii), Cu(ii), Ni(ii) and Zn(ii) chelates of ferrocenyl-1-thiadiazolo-1′-tetrazole, -1-thiadiazolo-1′-triazole and -1-tetrazolo-1′-triazole with antimicrobial properties. J Enzyme Inhib Med Chem 2002;17:261–6
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77
   PubMed Web of Science ®Google Scholar
• McDonald PC, Winum JY, Supuran CT, Dedhar S. Recent development in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 2012;3:84–97
   PubMed Web of Science ®Google Scholar
• Guler OO, De Simone G, Supuran CT. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII. Curr Med Chem 2010;17:1516–26
   PubMed Web of Science ®Google Scholar
• Tars K, Vullo D, Kazaks A, et al. Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013;56:293–300
   PubMed Web of Science ®Google Scholar
• Ceruso M, Bragagni M, AlOthman Z, et al. New series of sulfonamides containing amino acid moiety act as a effective and selective inhibitors of tumor-associated carbonic anhydrase XII. J Enzyme Inhib Med Chem 2014;4:1–5
   Google Scholar
• Thibaudeau S, Martin-Mingot A, Jouannetaud M-P, et al. A novel, facile route to β-fluoroamines by hydrofluorination using superacid HF-SbF5. Chem Commun 2007:3198–200
   PubMed Web of Science ®Google Scholar
• Vardelle E, Gamba-Sanchez D, Martin-Mingot A, et al. Cyclisation/fluorination of nitrogen containing dienes in superacid HF-SbF5: a new route to 3- and 4-fluoropiperidines. Chem Commun 2008:1473–5
   PubMed Web of Science ®Google Scholar
• Liu F, Martin-Mingot A, Jouannetaud M-P, et al. Superelectrophilic activation in superacid HF/SbF5 and synthesis of benzofused sultams. Org Lett 2010;12:868–71
   PubMed Web of Science ®Google Scholar
• Compain G, Martin-Mingot A, Frapper G, et al. Anti-Markovnikov additions to N-allylic derivatives involving ammonium–carbenium superelectrophiles. Chem Commun 2012;48:5877–9
   PubMed Web of Science ®Google Scholar
• Compain G, Jouvin K, Martin-Mingot A, et al. Stereoselective hydrofluorination of ynamides: a straightforward synthesis of novel α-fluoroenamides. Chem Commun 2012;48:5196–8
   PubMed Web of Science ®Google Scholar
• Métayer B, Mingot A, Vullo D, et al. New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides. Chem Commun 2013;49:6015–17
   PubMed Web of Science ®Google Scholar
• Métayer B, Mingot A, Vullo D, et al. Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: toward understanding a new mode of inhibition by tertiary sulfonamides. Org Biomol Chem 2013;43:7540–9
   Web of Science ®Google Scholar
• Compain G, Martin-Mingot A, Maresca A, et al. Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors. Bioorg Med Chem 2013;21:1555–63
   PubMed Web of Science ®Google Scholar
• Maresca A, Scozzafava A, Supuran CT. 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. Bioorg Med Chem Lett 2010;20:7255–8
   PubMed Web of Science ®Google Scholar
• Maresca A, Supuran CT. Coumarins incorporating hydroxyl- and chloro-moities selectively inhibit the transmembrane tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II. Bioorg Med Chem Lett 2010;20:4511–14
   PubMed Web of Science ®Google Scholar
• Grandane A, Tanc M, Zalubovskis R, Supuran CT. Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem 2014;22:1522–8
   PubMed Web of Science ®Google Scholar
• Lau J, Pan J, Zhang Z, et al. Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography. Bioorg Med Chem Lett 2014;24:3064–8
   PubMed Web of Science ®Google Scholar
• D'Ascenzio M, Carradori S, De Monte C, et al. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII. Bioorg Med Chem 2014;22:1821–31
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Scozzafava A, et al. The coumarin-binding site in carbonic anhydrase accomodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors. J Med Chem 2010;53:850–4
   PubMed Web of Science ®Google Scholar
• Biswas S, Aggarwal M, Güzel Ö, et al. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to different binding in the active site of the cytosolic human carbonic anhydrase isoforms. Bioorg Med Chem 2011;19:3732–8
   PubMed Web of Science ®Google Scholar
• Abbate F, Coetzee A, Casini A, et al. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. Bioorg Med Chem Lett 2004;14:337–41
   PubMed Web of Science ®Google Scholar
• Abbate F, Casini A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide: implications for the drug design of fluorinated inhibitors. J Enzyme Inhib Med Chem 2003;18:303–8
   PubMed Web of Science ®Google Scholar
• Begue J-P, Bonnet-Delpon D. Bioorganic and medicinal chemistry of fluorine. Hoboken (NJ): Wiley; 2008
   Google Scholar
• Wang J, Sanchez-Rosello M, Acena JL, et al. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011). Chem Rev 2014;114:2432–506
   PubMed Web of Science ®Google Scholar
• Morgenthaler M, Schweiser E, Hoffman-Röder A, et al. Predicting and tuning physiochemical properties in lead optimization: amine basicities. Chem Med Chem 2007;2:1100–15
   Web of Science ®Google Scholar
• Müller K, Faeh C, Diederich F. Fluorine in pharmaceuticals: looking beyond intuition. Science 2007;317:1881–6
   PubMed Web of Science ®Google Scholar
• Böhm H-J, Banner D, Bendels S, et al. Fluorine in medicinal chemistry. Chem Bio Chem 2004;5:637–43
   Web of Science ®Google Scholar
• Hu X-G, Hunter L. Stereoselectively fluorinated N-heterocycles: a brief survey. Beilstein J Org Chem 2013;9:2696–708
   PubMed Web of Science ®Google Scholar
• For a recent review, please see: Hunter L. The C-F bond as a conformational tool in organic and biological chemistry. Beilstein J Org Chem 2010;6:38
   PubMed Web of Science ®Google Scholar
• For a recent article, please see: Yamamoto I, Jordan MJT, Gavande N, et al. The enantiomers of syn-2,3-difluoro-4-aminobutyric acid elicit opposite responses at the GABAc receptor. Chem Commun 2012;48:829–31
   PubMed Web of Science ®Google Scholar
• Ceruso M, Vullo D, Scozzafava A, Supuran CT. Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2014;25:686–9
   Web of Science ®Google Scholar
• Khalifah RG. Carbon dioxide hydratation activity of carbonic anhydrase: kinetics of alkylated anhydrases B and C from humans. J Biol Chem 1971;246:2561–73
   PubMed Web of Science ®Google Scholar
• Rami M, Maresca A, Smaine F-Z, et al. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem Lett 2011;21:2975–9
   PubMed Web of Science ®Google Scholar
• Capkauskaite E, Baranauskiene L, Golovenko D, et al. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII. Bioorg Med Chem 2010;18:7357–64
   PubMed Web of Science ®Google Scholar
• Mader P, Brynda J, Gitto R, et al. Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides. J Med Chem 2011;54:2522–6
   PubMed Web of Science ®Google Scholar
• Mincione F, Benedini F, Biondi S, et al. Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. Bioorg Med Chem Lett 2011;21:3216–21 
   PubMed Web of Science ®Google Scholar
• Bertucci A, Innocenti A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. Bioorg Med Chem Lett 2011;21:710–14
   PubMed Web of Science ®Google Scholar
• Hen N, Bialer M, Yagen B, et al. Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV. J Med Chem 2011;54:3977–81
   PubMed Web of Science ®Google Scholar
• Botrè F, Botrè C, Podestà E, et al. Effect of anti-carbonic anhydrase antibodies on carbonic anhydrases I and II. Clin Chem 2003;49:1221–3
   PubMed Web of Science ®Google Scholar
• Bosley TM, Salih MA, Alorainy IA, et al. The neurology of carbonic anhydrase type II deficiency syndrome. Brain 2011;134:3499–512
   Web of Science ®Google Scholar